Jia-sheng Zheng

Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation.

Yang Zhang, D. Wei, H. Bian, 2014, Journal of the National Cancer Institute.

Oncotargets and Therapy

Jia-sheng Zheng, Dao-jie Liu, Bin Sun, 2022 .

Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study

J. Long, Jia-sheng Zheng, Bin Sun, 2016, Hepatology International.

Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?

J. Long, Jia-sheng Zheng, N. Du, 2014, Clinical radiology.

An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma

Shengtao Zhu, Shengqi Wang, J. Jia, 2015, EBioMedicine.